216 related articles for article (PubMed ID: 3994179)
1. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs.
Peoples JB
Am Surg; 1985 Jun; 51(6):358-62. PubMed ID: 3994179
[TBL] [Abstract][Full Text] [Related]
2. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1993 Jul; 153(14):1665-70. PubMed ID: 8333804
[TBL] [Abstract][Full Text] [Related]
3. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
5. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
7. Antiinflammatory drugs and emergency surgery for peptic ulcers in the Waikato.
Keating J; Chandran H
N Z Med J; 1992 Apr; 105(931):127-9. PubMed ID: 1560923
[TBL] [Abstract][Full Text] [Related]
8. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
Wilcox CM; Shalek KA; Cotsonis G
Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
[TBL] [Abstract][Full Text] [Related]
9. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK; Castellsague J; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
[TBL] [Abstract][Full Text] [Related]
12. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting mortality in patients operated upon for complications of peptic ulcer disease.
Greiser WB; Bruner BW; Shamoun JM; Jurkovich GJ; Ferrara JJ
Am Surg; 1989 Jan; 55(1):7-11. PubMed ID: 2913910
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
[TBL] [Abstract][Full Text] [Related]
15. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
[TBL] [Abstract][Full Text] [Related]
16. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
[TBL] [Abstract][Full Text] [Related]
17. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
18. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
19. Acute upper gastrointestinal bleeding: comparison between recent users and nonusers of nonsteroidal anti-inflammatory drugs.
Adamopoulos A; Efstathiou S; Tsioulos D; Tsami A; Mitromaras A; Mountokalakis T
Endoscopy; 2003 Apr; 35(4):327-32. PubMed ID: 12664390
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
Graham DY
Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
